Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Central Coast Health Watch  -  Page 99

Dignity Health
Latest

Amgen drug Kyprolis gets another FDA approval

By   /  Thursday, January 21st, 2016  /  Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on Amgen drug Kyprolis gets another FDA approval

Amgen scored another victory for its breakthrough multiple myeloma drug on Jan. 21. The Thousand Oaks-based biotech giant hit it big when the Food and Drug Administration approved revolutionary multiple myeloma drug Kyprolis for treatments with Kyprolis in combination with another drug. The FDA also approved Kyprolis to treat patients on its own for those Read More →

Read More →
Latest

Shire buying Conejo Valley’s Baxalta

By   /  Friday, January 15th, 2016  /  Central Coast Health Watch, Top Stories, Top Story  /  Comments Off on Shire buying Conejo Valley’s Baxalta

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen suffers setback as patent office refuses to review competitor’s drug

By   /  Thursday, January 14th, 2016  /  Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on Amgen suffers setback as patent office refuses to review competitor’s drug

The U.S. Patent and Trademark Office handed Amgen a potential setback Jan. 14 when it declined to review two patent expiration dates on a competitor’s drug. In June, Thousand Oaks-based biotech giant Amgen asked the agency to review two formulation patents for Humira, made by Chicago-based competitor AbbVie, arguing that the patents should not have Read More →

Read More →
Latest

Shire acquiring Baxalta for $32 billion

By   /  Monday, January 11th, 2016  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Shire acquiring Baxalta for $32 billion

Shire PLC sweetened the pot and Baxalta Inc. investors took the bait in a deal announced early Jan. 11. Dublin-based Shire announced a $30 billion bid for Deefield, Ill.-based Baxalta on Aug. 4. On Jan. 11, the companies announced Shire will acquire Baxalta for $32 billion. Baxalta employs about 2,000 people in Thousand Oaks and Read More →

Read More →
Latest

Sientra implants could be back on the market in weeks

By   /  Friday, January 8th, 2016  /  Central Coast Health Watch, Latest news  /  Comments Off on Sientra implants could be back on the market in weeks

Sientra made three major announcements on Jan. 7: It is not yet resuming production at its factory in Rio de Janeiro, it is looking for a new manufacturer of its implants and the existing inventory could be back on the market within weeks. On Jan. 8, the British Medicines and Healthcare Products Regulatory Agency also Read More →

Read More →
Latest

Surgeons clamor for Sientra implants

By   /  Friday, January 8th, 2016  /  Central Coast Health Watch, Latest news, Top Stories, Top Story, Tri-County Public Companies  /  Comments Off on Surgeons clamor for Sientra implants

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Avoiding ER with Pre-R

By   /  Friday, January 8th, 2016  /  Central Coast, Central Coast Health Watch, right, Small Business, Top Stories  /  Comments Off on Avoiding ER with Pre-R

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →